Lenalidomide stops progression of multifocal epithelioid hemangioendothelioma including intracranial disease

Journal of Neuro-Oncology

Volumn 97, Issue 2, 2010, Pages 275-277

  Sumrall, Ashley ^a   Fredericks, Ruth ^a   Berthold, Anne ^b   Shumaker, Grace ^b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b Jackson Oncology Associates   (United States)

Author keywords

Intracranial; Lenalidomide; Multifocal epithelioid hemangioendothelioma; Treatment

Indexed keywords

ALPHA2B INTERFERON; CELECOXIB; CISPLATIN; DOXORUBICIN; IFOSFAMIDE; LENALIDOMIDE; THALIDOMIDE;

ADD ON THERAPY; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CANCER RADIOTHERAPY; CASE REPORT; CEREBROVASCULAR DISEASE; CERVICAL LYMPHADENOPATHY; CHEMOEMBOLIZATION; CLINICAL FEATURE; CRANIOTOMY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DIZZINESS; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; FEMALE; HEADACHE; HEMANGIOENDOTHELIOMA; HUMAN; LIVER METASTASIS; LUNG NODULE; LUNG TUMOR; MULTIPLE CYCLE TREATMENT; NEUROFIBROMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OTALGIA; PERIPHERAL NEUROPATHY; PREGNANCY; SCALP TUMOR; THORAX SCINTISCANNING; TUMOR RECURRENCE;

ADULT; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CLINICAL TRIALS AS TOPIC; FEMALE; HEMANGIOENDOTHELIOMA, EPITHELIOID; HUMANS; MAGNETIC RESONANCE IMAGING; THALIDOMIDE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77950458249     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-0017-z     Document Type: Article

References (10)

1. Fenniche S, Benmously R, Marrak H et al (2004) Cutaneous epithelioid hemangioendothelioma. Ann Dermatol Venereol 131(8-9):818-821
2. Puca A, Meglio M, Massimo R et al (1996) Intracranial epithe-lioid hemangioendothelioma: case report. Neurosurger 38(2): 399-401
3. Fernandes A, Ratilal B, Mafra M et al (2006) Aggressive intra-cranial and extracranial epithelioid hemangioendothelioma: a case report and review of the literature. Neuropathology 26(3): 201-205
4. Bollinger B, Laskin W, Knight C (1994) Epithelioid hemangio-endothelioma with multiple site involvement: literature review and observations. Cancer 73:610-615
5. Tsuneyoshi M, Dorfman H, Bauer T (1986) Epithelioid heman-gioendothelioma of bone: a clinicopathologic, ultrastructural, and immunohistochemical study. Am J Surg Pathol 10:754-756
6. Miller A, Case D, Harmon M (2007) Phase I Study of lenalido-mide in solid tumors. J Thorac Oncol 5:445-449
7. Mascarenhas R, Sanghvi A, Friedlander L et al (2004) Thalido-mide inhibits the growth and progression of hepatic epithelioid hemangioendothelioma. Oncology 67:471-475
8. Kalmadi S, Baz R, Mahindra A (2007) Lenalidomide: the emerging role of a novel targeted agent in malignancies. Drugs Today 43(2):85-95
9. Kastritis E, Dimopoulos M (2007) The evolving role of lenalid-omide in the treatment of hematologic malignancies. Expert Opin Pharmacother 8(4):497-509
10. Bartlett J, Michael A, Clarke I et al (2004) Phase I study to determine the safety, tolerability, and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic melanoma and other advanced cancers. Br J Cancer 90(5):955-961